Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ · Healthcare
Harmony Biosciences Holdings, Inc. Shareholder Equity 2020–2025
Harmony Biosciences Holdings, Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Harmony Biosciences Holdings, Inc. shareholder equity as of December 31, 2025: 870.2M, a 32.02% increase year-over-year.
- Harmony Biosciences Holdings, Inc. shareholder equity for 2025 were 870.2M, a 32.02% increase from 2024.
- Harmony Biosciences Holdings, Inc. shareholder equity for 2024 were 659.2M, a 41.15% increase from 2023.
- Harmony Biosciences Holdings, Inc. shareholder equity for 2023 were 467.0M, a 15.93% increase from 2022.
- Harmony Biosciences Holdings, Inc. shareholder equity for 2022 were 402.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Harmony Biosciences Holdings, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $870 |
| 2024 | $659 |
| 2023 | $467 |
| 2022 | $403 |
| 2021 | $187 |
| 2020 | $97 |
Harmony Biosciences Holdings, Inc. Shareholder Equity — FAQ
Harmony Biosciences Holdings, Inc. (HRMY) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see HRMY's shareholder equity history?
The chart and table above show Harmony Biosciences Holdings, Inc.'s shareholder equity by year and by quarter, including the growth rate.